Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Husa

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Klinicka Mikrobiologie a Infekcni Lekarstvi|May 4, 2017
[Standard diagnostic and therapeutic approach to chronic hepatitis C virus (HCV) infection 22 - guidelines]Petr Urbánek, Petr Husa, Stanislav Plíšek, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 20, 2014
[Diagnosis and therapy of Clostridium difficile infection: Czech national guidelines]Jiří Beneš, Petr Husa, Otakar Nyč, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2007
HFE C282Y gene variant is a risk factor for the progression to decompensated liver disease in chronic viral hepatitis C subjects in the Czech populationLukás Pácal, Petr Husa, Vladimír Znojil, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|February 13, 2019
[Guideline for fecal bacteriotherapy to treat recurrent Clostridium difficile colitis]Silvia Polívková, Lenka Vojtilová, Petr Husa, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 23, 2024
Oxidative stress, microparticles, and E-selectin do not depend on HIV suppressionKaterina Havlickova, Svatava Snopkova, Miroslav Pohanka, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 26, 2004
[Marseille fever imported from Spain]Michaela Freibergerová, Radana Parízková, Petr Husa, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 30, 2008
[Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics]Petr Husa, Pavel Slesinger, Hana Stroblová, et al.
European Journal of Internal Medicine|March 15, 2002
Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis BPetr Husa, Jarmila Klusáková, Jana Jancíková, et al.
Archives of Medical Science : AMS|September 26, 2022
Hepatitis E - epidemiology and clinical course in the largest cohort in the Czech RepublicMatúš Mihalčin, Libuse Husova, Petra Vasickova, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|October 14, 2021
[COVID-19: diagnosis and treatment]Marek Štefan, Aleš Chrdle, Petr Husa, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Klinicka Mikrobiologie a Infekcni Lekarstvi|May 4, 2017
[Standard diagnostic and therapeutic approach to chronic hepatitis C virus (HCV) infection 22 - guidelines]Petr Urbánek, Petr Husa, Stanislav Plíšek, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 20, 2014
[Diagnosis and therapy of Clostridium difficile infection: Czech national guidelines]Jiří Beneš, Petr Husa, Otakar Nyč, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2007
HFE C282Y gene variant is a risk factor for the progression to decompensated liver disease in chronic viral hepatitis C subjects in the Czech populationLukás Pácal, Petr Husa, Vladimír Znojil, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|February 13, 2019
[Guideline for fecal bacteriotherapy to treat recurrent Clostridium difficile colitis]Silvia Polívková, Lenka Vojtilová, Petr Husa, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 23, 2024
Oxidative stress, microparticles, and E-selectin do not depend on HIV suppressionKaterina Havlickova, Svatava Snopkova, Miroslav Pohanka, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 26, 2004
[Marseille fever imported from Spain]Michaela Freibergerová, Radana Parízková, Petr Husa, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 30, 2008
[Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics]Petr Husa, Pavel Slesinger, Hana Stroblová, et al.
European Journal of Internal Medicine|March 15, 2002
Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis BPetr Husa, Jarmila Klusáková, Jana Jancíková, et al.
Archives of Medical Science : AMS|September 26, 2022
Hepatitis E - epidemiology and clinical course in the largest cohort in the Czech RepublicMatúš Mihalčin, Libuse Husova, Petra Vasickova, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|October 14, 2021
[COVID-19: diagnosis and treatment]Marek Štefan, Aleš Chrdle, Petr Husa, et al.
Pageof 9